Aptamedicine: a new treatment modality in personalized cancer therapy

Somayeh Vandghanooni ¹, Morteza Eskandani ¹, Jaleh Barar ^1,2 , Yadollah Omidi ^1,2 *

Cited by CrossRef: 2

1- Fathi M, Safary A, Barar J. Therapeutic impacts of enzyme-responsive smart nanobiosystems. Bioimpacts. 2019;10(1):1 [Crossref]

2- Vandghanooni S, Jaymand M, Eskandani M. The use of nanomedicines in the healthcare systems: a policy brief. Drug Development and Industrial Pharmacy. 2025;:1 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons